A Novel Computer-Aid Nanotechnology Targeting to Combat Antibiotics Resistance with Superbugs against COVID-19 Pandemic

Microbial infections are still among the major public health concerns since several yeasts and fungi, and other pathogenic microorganisms, are responsible for continuous growth of infections and drug resistance against bacteria. During COVID-19 pandemic outbreak antimicrobial resistance rate is fostering the need to develop new strategies against drug-resistant superbugs. Thus, a novel technological approach on improving existing drugs is gaining special interest. Based on nano-medicine performance, successful experiments, and considerable market prospects, nanotechnology will undoubtedly lead a breakthrough in biomedical field also for infectious diseases, as there are several nanotechnological approaches that exhibit important roles in restoring antibiotic activity against resistant bacteria. Hence, the scientific community should also pay attention to developing affordable methodologies so that nanotechnology can reach patients.

Keywords: Nano-antibiotics; Bacterial and virus infections; COVID-19 pandemic; Antimicrobial resistance (AMR); Superbugs; Antimicrobial peptides